Literature DB >> 26546996

Hospital-Acquired Infections after Aneurysmal Subarachnoid Hemorrhage: A Nationwide Analysis.

Hormuzdiyar H Dasenbrock1, Robert F Rudy2, Timothy R Smith1, Donovan Guttieres3, Kai U Frerichs1, William B Gormley1, M Ali Aziz-Sultan1, Rose Du4.   

Abstract

BACKGROUND: This is the first nationwide study to evaluate the factors associated with developing hospital-acquired infections (HAIs) after aneurysmal subarachnoid hemorrhage (SAH) and analyze their impact on the efficiency of hospital care.
METHODS: Data from patients with SAH who underwent aneurysm repair were extracted from the Nationwide Inpatient Sample (2008-2011). Urinary tract infections, pneumonia, central venous catheter (CVC)-associated blood stream infection, and meningitis/ventriculitis were evaluated. Independent predictors of HAIs used in multivariable logistic regression modeling were chosen using forward selection; hierarchical multivariable linear regression assessed length of stay and charges.
RESULTS: Seven thousand five hundred sixteen admissions were included. Independent predictors in the logistic regression for developing a urinary tract infection (23.9%) included older age, female sex, noninfectious complications (P < 0.001), intracerebral hemorrhage (P = 0.009), and diabetes with complications (P = 0.04). Pneumonia (23.0%) was associated with older age (P = 0.003), congestive heart failure, severity of SAH, and noninfectious complications (P < 0.001). Severity of SAH and noninfectious complications were predictors of meningitis/ventriculitis (4.4%; P ≤ 0.02), whereas intracerebral hemorrhage and noninfectious complications were predictors of CVC-associated infections (1.0%; P ≤ 0.02). All HAIs were associated with significantly longer hospitalizations and higher charges. Pneumonia (odds ratio [OR], 2.85; 95% confidence interval (CI), 2.44-3.34) and CVC-associated infections (OR, 2.42; 95% CI, 1.26-4.66) were also independently associated with greater odds of poor outcome (death or institutional care).
CONCLUSION: In this nationwide analysis, urinary tract infections and pneumonia were the most common hospital-acquired infections after SAH. Although all infections were associated with significantly longer hospitalizations and greater charges, pneumonia and CVC-associated infections were also associated with increased likelihood of a poor outcome.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral aneurysm; Hospital-acquired infection; Meningitis; National Surgical Quality Improvement Program; Nationwide Inpatient Sample; Pneumonia; Subarachnoid hemorrhage; Urinary tract infection

Mesh:

Year:  2015        PMID: 26546996     DOI: 10.1016/j.wneu.2015.10.054

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  15 in total

1.  Comparative Analyses of the Impact of Different Criteria for Sepsis Diagnosis on Outcome in Patients with Spontaneous Subarachnoid Hemorrhage.

Authors:  Franz-Simon Centner; Mariella Eliana Oster; Franz-Joseph Dally; Johannes Sauter-Servaes; Tanja Pelzer; Jochen Johannes Schoettler; Bianka Hahn; Anna-Meagan Fairley; Amr Abdulazim; Katharina Antonia Margarete Hackenberg; Christoph Groden; Nima Etminan; Joerg Krebs; Manfred Thiel; Holger Wenz; Máté Elod Maros
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

2.  Association Between Serum Albumin and Hospital-Acquired Infections After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Peng Wang; Yu Zhang; Xing Wang; Liyuan Peng; Lu Jia; Tiangui Li; Weelic Chong; Yang Hai; Chao You; Fang Fang
Journal:  Neurocrit Care       Date:  2021-12-30       Impact factor: 3.532

3.  Stroke-associated infection independently predicts 3-month poor functional outcome and mortality.

Authors:  Satoshi Suda; Junya Aoki; Takashi Shimoyama; Kentaro Suzuki; Yuki Sakamoto; Takehiro Katano; Seiji Okubo; Chikako Nito; Yasuhiro Nishiyama; Masahiro Mishina; Kazumi Kimura
Journal:  J Neurol       Date:  2017-12-16       Impact factor: 4.849

4.  Clinical and Laboratory Characteristics for the Diagnosis of Bacterial Ventriculitis After Aneurysmal Subarachnoid Hemorrhage.

Authors:  J Hoogmoed; D van de Beek; B A Coert; J Horn; W P Vandertop; D Verbaan
Journal:  Neurocrit Care       Date:  2017-06       Impact factor: 3.210

5.  Hydroxyethyl starch for volume expansion after subarachnoid haemorrhage and renal function: Results of a retrospective analysis.

Authors:  Sven Bercker; Tanja Winkelmann; Thilo Busch; Sven Laudi; Dirk Lindner; Jürgen Meixensberger
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

6.  Outcome Following the Treatment of Ventriculitis Caused by Multi/Extensive Drug Resistance Gram Negative Bacilli; Acinetobacter baumannii and Klebsiella pneumonia.

Authors:  Sajan Pandey; Lei Li; Xian Yu Deng; Da Ming Cui; Liang Gao
Journal:  Front Neurol       Date:  2019-01-23       Impact factor: 4.003

7.  Impact of Complications and Comorbidities on the Intensive Care Length of Stay after Aneurysmal Subarachnoid Haemorrhage.

Authors:  Alexander Hammer; Gholamreza Ranaie; Frank Erbguth; Matthias Hohenhaus; Martin Wenzl; Monika Killer-Oberpfalzer; Hans-Herbert Steiner; Hendrik Janssen
Journal:  Sci Rep       Date:  2020-04-10       Impact factor: 4.379

8.  Neurocritical care complications and interventions influence the outcome in aneurysmal subarachnoid hemorrhage.

Authors:  Alexander Hammer; Frank Erbguth; Matthias Hohenhaus; Christian M Hammer; Hannes Lücking; Markus Gesslein; Monika Killer-Oberpfalzer; Hans-Herbert Steiner; Hendrik Janssen
Journal:  BMC Neurol       Date:  2021-01-19       Impact factor: 2.474

9.  Complications of external cerebrospinal fluid drainage in aneurysmal subarachnoid haemorrhage.

Authors:  Sebastian Arts; Erik J van Lindert; Rene Aquarius; Ronald H M A Bartels; Hieronymus D Boogaarts
Journal:  Acta Neurochir (Wien)       Date:  2021-01-02       Impact factor: 2.216

10.  Subarachnoid Hemorrhage "Fast Track": A Health Economics and Health Care Redesign Approach for Early Selected Hospital Discharge.

Authors:  Christina I Collins; Tasneem F Hasan; Lesia H Mooney; Jessica L Talbot; Amanda L Fouraker; Katherine F Nelson; MaryAnn Ohanian; Stephanie L Bonnett; Rabih G Tawk; Lisa M Nordan; David O Hodge; Robert S Kaplan; Benjamin L Thiemann; Meredith Karney; William D Freeman
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.